Nicaraven-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Nicaraven-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Nicaraven-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
Nicaraven-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemENicaravenCat. No.: HY-100592CAS No.: 79455-30-4分式: CHNO分量: 284.31作靶點(diǎn): Others作通路: Others儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (351.73 mM)H2O : 50 mg/mL (175.86 mM)* means

2、 soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 3.5173 mL 17.5864 mL 35.1729 mL5 mM 0.7035 mL 3.5173 mL 7.0346 mL10 mM 0.3517 mL 1.7586 mL 3.5173 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn)請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍福渲魄罢?qǐng)先配制澄清的儲(chǔ)備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您

3、現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.75 mg/mL (9.67 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.75 mg/mL (9.67 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.Med

4、ChemE3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.75 mg/mL (9.67 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Nicaraven種新穎的化學(xué)合成的羥 由基清除劑。體外研究 The maximum aggregation rate induced by adenosine diphosphate (ADP) is significantly inhibited bynicaraven at concentration ranges of 350 M or higher in the h

5、ealthy volunteer platelets. The maximumaggregation rate induced by collagen is significantly inhibited by 1.75 mM of nicaraven 1.體內(nèi)研究 Nicaraven inhibits lipid peroxidation in the liver, improves hepatic and systemic hemodynamics and energymetabolism, and suppresses liver enzyme release, endothelin-1

6、 elevation in hepatic venous blood, histologicdamage, and neutrophil infiltration into the liver 1. Nicaraven increases the number of c-kit(+)stem/progenitor cells in bone marrow and peripheral blood, with a recovery rate around 60-90% of age-matched non-irradiated healthy mice. The potency of colon

7、y forming from hematopoietic stem/progenitorcells as indicator of function is completely protected with nicaraven treatment 2. Administration of nicaravensignificantly increases the number, improves the colony-forming capacity, and decreases the DNA damage ofhematopoietic stem/progenitor cells. The

8、urinary levels of 8-oxo-2-deoxyguanosine, a marker of DNAoxidation, are significantly lower in mice that are given nicaraven compared with those that receive aplacebo. The administration of nicaraven significantly decreases the levels of the inflammatory cytokines IL-6and TNF- in the plasma of mice

9、3.PROTOCOLAnimal Mice: To investigate the protective effect and related mechanisms of nicaraven on radiation-induced injury inAdministration 3 hematopoietic stem/progenitor cells, 12 mice are exposed to 1 Gy -rays daily for 5 days in succession (atotal of 5 Gy) and are then given intraperitoneal inj

10、ections of nicaraven (100 mg/kg/day, Nicaraven group;n=6) or saline only (Placebo group; n=6), respectively, soon after each exposure. The mice are sacrificed 2days after the last exposure, and samples of urine, blood, and bone marrow cells are collected and used forthe following experiments 3.MCE h

11、as not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Komiya T, et al. A novel free radical scavenger, nicaraven, inhibits human platelet aggregation in vitro. Clin Neuropharmacol. 1999 Jan-Feb;22(1):11-4.2. Yokota R, et al. A novel hydroxyl radical s

12、cavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery.2000 Jun;127(6):661-9.3. Ali H, et al. The potential benefits of nicaraven to protect against radiation-induced injury in hematopoietic stem/progenitor cells withrelative low dose exposures.4. Nicaraven attenuates radiation-induced injury in hematopoietic stem/progenitor cells in mice. PLoS One. 2013;8(3):e60023.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEMcePdfHeightCa

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論